Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study (Q46938140)
Jump to navigation
Jump to search
scientific article published in October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study |
scientific article published in October 2007 |
Statements
1 reference
Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study (English)
1 reference
Hanefeld M
1 reference
Pfützner A
1 reference
Lübben G
1 reference
Weber MM
1 reference
Karagiannis E
1 reference
Köhler C
1 reference
Hohberg C
1 reference
Forst T
1 reference
1 October 2007
1 reference
1 reference
39
1 reference
764-768
1 reference
10
1 reference
Identifiers
1 reference
1 reference